Catasys Inc. (NASDAQ:CATS) has been assigned an average broker rating score of 1.50 (Buy) from the two brokers that cover the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a buy rating and one has assigned a strong buy rating to the company. Catasys’ rating score has declined by 50% in the last 90 days as a result of a number of analysts’ upgrades and downgrades.
Brokers have set a 12-month consensus price objective of $10.00 for the company and are anticipating that the company will post ($0.16) EPS for the current quarter, according to Zacks. Zacks has also assigned Catasys an industry rank of 185 out of 265 based on the ratings given to related companies.
Several brokerages have issued reports on CATS. Taglich Brothers began coverage on shares of Catasys in a research report on Wednesday, October 18th. They issued a “speculative buy” rating and a $8.00 price objective for the company. Telsey Advisory Group began coverage on shares of Catasys in a research report on Wednesday, October 18th. They set a “buy” rating for the company. Zacks Investment Research raised shares of Catasys from a “sell” rating to a “hold” rating in a research report on Monday, August 7th. Finally, ValuEngine downgraded shares of Catasys from a “hold” rating to a “sell” rating in a research report on Saturday, October 21st.
Catasys (NASDAQ CATS) traded down 0.97% during trading on Thursday, reaching $3.71. The company’s stock had a trading volume of 30,631 shares. Catasys has a 12 month low of $3.34 and a 12 month high of $14.00. The company’s market cap is $58.95 million. The stock’s 50 day moving average is $4.50 and its 200 day moving average is $4.91.
Catasys (NASDAQ:CATS) last issued its quarterly earnings data on Tuesday, August 15th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.20) by ($0.03). The business had revenue of $1.67 million for the quarter. On average, equities analysts expect that Catasys will post ($1.14) EPS for the current fiscal year.
Several hedge funds have recently added to or reduced their stakes in CATS. Perkins Capital Management Inc. acquired a new stake in shares of Catasys during the second quarter worth approximately $113,000. UBS Oconnor LLC acquired a new stake in shares of Catasys during the second quarter worth approximately $834,000. Bard Associates Inc. acquired a new stake in shares of Catasys during the second quarter worth approximately $1,012,000. Kennedy Capital Management Inc. acquired a new stake in shares of Catasys during the second quarter worth approximately $1,385,000. Finally, FNY Partners Fund LP acquired a new stake in shares of Catasys during the second quarter worth approximately $1,560,000. 7.26% of the stock is owned by institutional investors and hedge funds.
Catasys Company Profile
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The companys OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Catasys Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Catasys Inc. and related companies.